FDA approves Artivion’s AMDS device PMA
The approval was based on data from the PERSEVERE US IDE trial, which included 93 participants.
Analysis
View MoreTracking carbon, tracing change
To track and verify embodied emissions through every stage of the supply chain, leading OEMs are piloting blockchain-anchored digital product passports (DPPs). Ellie Philpotts talks to Chris Taylor, sustainability lead...
Go with the flow
Harnessing automation
How smart can it be?
Killer nanopatterns